196 related articles for article (PubMed ID: 21656856)
1. CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-γ/CXCL10-mediated apoptosis.
Tirotta E; Ransohoff RM; Lane TE
Glia; 2011 Oct; 59(10):1518-28. PubMed ID: 21656856
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling.
Tirotta E; Kirby LA; Hatch MN; Lane TE
Stem Cell Res; 2012 Nov; 9(3):208-17. PubMed ID: 22885102
[TBL] [Abstract][Full Text] [Related]
3. CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination.
Hosking MP; Tirotta E; Ransohoff RM; Lane TE
PLoS One; 2010 Jun; 5(6):e11340. PubMed ID: 20596532
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells.
Chew LJ; King WC; Kennedy A; Gallo V
Glia; 2005 Nov; 52(2):127-43. PubMed ID: 15920731
[TBL] [Abstract][Full Text] [Related]
5. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
[TBL] [Abstract][Full Text] [Related]
6. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor.
Garwood J; Garcion E; Dobbertin A; Heck N; Calco V; ffrench-Constant C; Faissner A
Eur J Neurosci; 2004 Nov; 20(10):2524-40. PubMed ID: 15548197
[TBL] [Abstract][Full Text] [Related]
7. CXCR2 Signaling and Remyelination in Preclinical Models of Demyelination.
Skinner DD; Lane TE
DNA Cell Biol; 2020 Jan; 39(1):3-7. PubMed ID: 31851535
[TBL] [Abstract][Full Text] [Related]
8. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.
Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM
J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
Padovani-Claudio DA; Liu L; Ransohoff RM; Miller RH
Glia; 2006 Oct; 54(5):471-83. PubMed ID: 16886211
[TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration.
Tsai HH; Frost E; To V; Robinson S; Ffrench-Constant C; Geertman R; Ransohoff RM; Miller RH
Cell; 2002 Aug; 110(3):373-83. PubMed ID: 12176324
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10.
Zhang Y; Gao Z; Wang D; Zhang T; Sun B; Mu L; Wang J; Liu Y; Kong Q; Liu X; Zhang Y; Zhang H; He J; Li H; Wang G
J Neuroinflammation; 2014 Apr; 11():79. PubMed ID: 24742325
[TBL] [Abstract][Full Text] [Related]
12. Cooperative contributions of interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells.
Horiuchi M; Itoh A; Pleasure D; Ozato K; Itoh T
J Neuroinflammation; 2011 Jan; 8():8. PubMed ID: 21261980
[TBL] [Abstract][Full Text] [Related]
13. Heparanome-Mediated Rescue of Oligodendrocyte Progenitor Quiescence following Inflammatory Demyelination.
Saraswat D; Welliver RR; Ravichandar R; Tripathi A; Polanco JJ; Broome J; Hurley E; Dutta R; Feltri ML; Sim FJ
J Neurosci; 2021 Mar; 41(10):2245-2263. PubMed ID: 33472827
[TBL] [Abstract][Full Text] [Related]
14. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.
Asensio VC; Maier J; Milner R; Boztug K; Kincaid C; Moulard M; Phillipson C; Lindsley K; Krucker T; Fox HS; Campbell IL
J Virol; 2001 Aug; 75(15):7067-77. PubMed ID: 11435587
[TBL] [Abstract][Full Text] [Related]
15. CXCL10/CXCR3 signaling mediates inhibitory action by interferon-gamma on CRF-stimulated adrenocorticotropic hormone (ACTH) release.
Horiguchi K; Fujiwara K; Tsukada T; Yoshida S; Higuchi M; Tateno K; Hasegawa R; Takigami S; Ohsako S; Yashiro T; Kato T; Kato Y
Cell Tissue Res; 2016 May; 364(2):395-404. PubMed ID: 26572542
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-γ.
Tanner DC; Cherry JD; Mayer-Pröschel M
J Neurosci; 2011 Apr; 31(16):6235-46. PubMed ID: 21508246
[TBL] [Abstract][Full Text] [Related]
17. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
18. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma.
Balabanov R; Strand K; Kemper A; Lee JY; Popko B
J Neurosci; 2006 May; 26(19):5143-52. PubMed ID: 16687505
[TBL] [Abstract][Full Text] [Related]
20. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
